Trial Profile
Conbercept in Choroidal Neovascularization Secondary to Uveitis
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2018
Price :
$35
*
At a glance
- Drugs Conbercept (Primary)
- Indications Choroidal neovascularisation; Uveitis
- Focus Therapeutic Use
- 20 Oct 2016 New trial record